91 related articles for article (PubMed ID: 28645931)
21. The paradox of the unfolded protein response in cancer.
Vandewynckel YP; Laukens D; Geerts A; Bogaerts E; Paridaens A; Verhelst X; Janssens S; Heindryckx F; Van Vlierberghe H
Anticancer Res; 2013 Nov; 33(11):4683-94. PubMed ID: 24222102
[TBL] [Abstract][Full Text] [Related]
22. Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients.
Alter M; Satzger I; Schrem H; Kaltenborn A; Kapp A; Gutzmer R
J Dtsch Dermatol Ges; 2014 Jun; 12(6):480-8. PubMed ID: 24813579
[TBL] [Abstract][Full Text] [Related]
23. Stress-responsive regulation of mitochondria through the ER unfolded protein response.
Rainbolt TK; Saunders JM; Wiseman RL
Trends Endocrinol Metab; 2014 Oct; 25(10):528-37. PubMed ID: 25048297
[TBL] [Abstract][Full Text] [Related]
24. For organ transplant recipients, cancer threatens long-term survival.
Ross K
J Natl Cancer Inst; 2007 Mar; 99(6):421-2. PubMed ID: 17374827
[No Abstract] [Full Text] [Related]
25. Skin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repair.
Kuschal C; Thoms KM; Schubert S; Schäfer A; Boeckmann L; Schön MP; Emmert S
Exp Dermatol; 2012 Jan; 21(1):2-6. PubMed ID: 22151386
[TBL] [Abstract][Full Text] [Related]
26. Hyperuricaemia in cyclosporin-treated patients: GFR-related effect.
Zürcher RM; Bock HA; Thiel G
Nephrol Dial Transplant; 1996 Jan; 11(1):153-8. PubMed ID: 8649625
[TBL] [Abstract][Full Text] [Related]
27. Cyclosporin-induced gingival overgrowth: a clinical-epidemiological evaluation of 121 Italian renal transplant recipients.
Vescovi P; Meleti M; Manfredi M; Merigo E; Pedrazzi G
J Periodontol; 2005 Aug; 76(8):1259-64. PubMed ID: 16101356
[TBL] [Abstract][Full Text] [Related]
28. Modulation of the unfolded protein response impedes tumor cell adaptation to proteotoxic stress: a PERK for hepatocellular carcinoma therapy.
Vandewynckel YP; Laukens D; Bogaerts E; Paridaens A; Van den Bussche A; Verhelst X; Van Steenkiste C; Descamps B; Vanhove C; Libbrecht L; De Rycke R; Lambrecht BN; Geerts A; Janssens S; Van Vlierberghe H
Hepatol Int; 2015 Jan; 9(1):93-104. PubMed ID: 25598862
[TBL] [Abstract][Full Text] [Related]
29. The unfolded protein response in plants: a fundamental adaptive cellular response to internal and external stresses.
Duwi Fanata WI; Lee SY; Lee KO
J Proteomics; 2013 Nov; 93():356-68. PubMed ID: 23624343
[TBL] [Abstract][Full Text] [Related]
30. Non-lymphoid cancer after liver transplantation.
Frezza EE; Fung JJ; van Thiel DH
Hepatogastroenterology; 1997; 44(16):1172-81. PubMed ID: 9261620
[TBL] [Abstract][Full Text] [Related]
31. [Immunosuppressive drugs and the development of skin cancer after organ transplantation].
Gjersvik P; Helsing P; Holdaas H; Bergan S
Tidsskr Nor Laegeforen; 2012 Oct; 132(18):2064-8. PubMed ID: 23038197
[TBL] [Abstract][Full Text] [Related]
32. The endoplasmic reticulum stress/unfolded protein response in gliomagenesis, tumor progression and as a therapeutic target in glioblastoma.
Peñaranda Fajardo NM; Meijer C; Kruyt FA
Biochem Pharmacol; 2016 Oct; 118():1-8. PubMed ID: 27106078
[TBL] [Abstract][Full Text] [Related]
33. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
34. Individual variability in cyclosporin A sensitivity: the assessment of functional measures on CD28-mediated costimulation of human whole blood T lymphocytes.
Härtel C; Hammers HJ; Schlenke P; Fricke L; Schumacher N; Kirchner H; Müller-Steinhardt M
J Interferon Cytokine Res; 2003 Feb; 23(2):91-9. PubMed ID: 12744774
[TBL] [Abstract][Full Text] [Related]
35. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
36. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.
Agarwal SK; Bhowmik D; Mahajan S; Bagchi S
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27775825
[TBL] [Abstract][Full Text] [Related]
37. [Involvement of endoplasmic reticulum stress in solid organ transplantation].
Pallet N; Bouvier N; Beaune P; Legendre C; Anglicheau D; Thervet E
Med Sci (Paris); 2010 Apr; 26(4):397-403. PubMed ID: 20412745
[TBL] [Abstract][Full Text] [Related]
38. Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control.
Connolly K; Manders P; Earls P; Epstein RJ
Cancer Treat Rev; 2014 Mar; 40(2):205-14. PubMed ID: 24051018
[TBL] [Abstract][Full Text] [Related]
39. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.
Benigni A; Bruzzi I; Mister M; Azzollini N; Gaspari F; Perico N; Gotti E; Bertani T; Remuzzi G
Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092
[TBL] [Abstract][Full Text] [Related]
40. Immunosuppressant use without bone loss--implications for bone loss after transplantation.
Goodman GR; Dissanayake IR; Sodam BR; Gorodetsky E; Lu J; Ma YF; Jee WS; Epstein S
J Bone Miner Res; 2001 Jan; 16(1):72-8. PubMed ID: 11149492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
